What We're Reading: Page 238
Industry reads hand-picked by our editors
Sep 18, 2018
-
The Washington Post
China says it will immediately retaliate when Trump tariffs take effect
-
RAPS
Australia Unveils Strategy for Engaging With Foreign Regulators
-
The Wall Street Journal
Senate Passes Bipartisan Legislation to Combat Opioid Epidemic
-
MobiHealthNews
AliveCor previews next product: A 6-lead smartphone ECG
Sep 17, 2018
-
The Wall Street Journal
Wearable Health Monitors: Do They Work?
-
CNBC
Heart health start-up AliveCor could have been crushed by Apple Watch announcement — but the opposite is happening so far
-
The New York Times
Low-Dose Aspirin Late in Life? Healthy People May Not Need It
-
Bloomberg
Yes, the Tax Cuts Have Cost the U.S. Treasury Money
Sep 14, 2018
-
STAT News
She’s been helping Republicans on Capitol Hill oversee the FDA for years. Now, she’ll be its top lawyer
-
Washington Examiner
Jeff Sessions to DOJ lawyers: Resist nationwide injunctions
-
The New York Times
Top Sloan Kettering Cancer Doctor Resigns After Failing to Disclose Industry Ties
-
Modern Healthcare
Opioid use disorder cases triple government's early estimates
Sep 13, 2018
-
Kaiser Health News
Trying To Protect Seniors, The Most Vulnerable, From Formidable Foe Florence
-
Politico
Trump accuses Democrats of inflating Puerto Rico death toll
-
South Morning China Post
Chinese stent one big step closer to breaking into the European market
-
Bloomberg
Trump Eyeing ‘Disruptive’ Changes to Drug Pricing, Health Secretary Says
Sep 12, 2018
-
The New York Times
F.D.A. Cracks Down on Juul and E-Cigarette Retailers
-
The Wall Street Journal
Nearly 600 Russia-Linked Accounts Tweeted About the Health Law
-
Forbes
Low Health Literacy Costs U.S. Employers $5 Billion A Year
-
Medtech Insight
Start-Up Spotlight: Creavo Medical, Diagnosing Myocardial Ischaemia With MCG
Sep 11, 2018
-
STAT News
Controversial contraception app approved in U.S. drawing scrutiny overseas
-
RAPS
Health Canada to Pilot New Meeting Framework for Preclinical Advice on Devices
-
Financial Times
Pharma chief defends 400% drug price rise as a ‘moral requirement’
-
MassDevice
Insider trading ring draws another guilty plea
Sep 10, 2018
-
The New York Times
Vaccines Against H.I.V., Malaria and Tuberculosis Unlikely, Study Says
-
Medtech Insight
From White House To White Oak: US FDA Taps Stacy Cline Amin For Chief Counsel Post
-
Kaiser Health News
The Remedy For Surprise Medical Bills May Lie In Stitching Up Federal Law
-
The Wall Street Journal
Cheap Custom-Made Versions of High-Cost Drugs Spur Backlash
Previous
